Previous 10 | Next 10 |
BioTelemetry, the primary and only real contender for iRhythm, was just acquired by tech giant Philips. BioTelemetry's product line will be rapidly placed on the forefront of the Philips' Connected Care Solutions business, which will vastly diminish the available market size for iRhyt...
The rapid adoption of telemedicine and digital health during COVID-19 pandemic is remarkable, yet unsurprising. In the years preceding the health crisis we now find ourselves in, a paradigm shift in health care toward digitization was percolating. In the following piece, we explor...
iRhythm Technologies (IRTC) announces the retirement of Kevin King as president and CEO, effective Jan. 12, 2021.Under King’s leadership, iRhythm successfully completed an IPO in 2016 with its annual revenue growing from ~$5M in 2011 to projected analyst consensus of $263M in...
SAN FRANCISCO, Dec. 14, 2020 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, today announced that Kevin King will retire as President and CEO effective January 12, 2021....
Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), is investigating claims on behalf of investors of iRhythm Technologies (NasdaqGS: IRTC). Such investors are advised to contact KSF Managing Pa...
IRhythm Technologies ([[IRTC]] -19.3%) is down on almost a 10x surge in volume in apparent response to a final rule on 2021 reimbursement codes from the U.S. Centers for Medicare and Medicaid Services ((CMS)).Beginning on January 1, 2021, there will be two new Category I CPT code sets related...
Gainers: NanoVibronix (NAOV) +99%.Merrimack Pharmaceuticals (MACK) +46%.Catabasis Pharmaceuticals (CATB) +44%.Tredegar (TG) +27%.Intec Pharma (NTEC) +27%.Kingsway Financial Services (KFS) +25%.Sequential Brands (SQBG) +23%.Sequans Communications (SQNS) +20%.Mmtec (MTC) +20%.Callon Petrol...
Shares of iRhythm Technologies (NASDAQ: IRTC) were tanking on Wednesday, down 18.5% as of 11:30 a.m. EST. The steep decline came after the Centers for Medicare and Medicaid Services (CMS) announced its 2021 Medicare Physician Fee Schedule (MPFS) Final Rule. The MPFS Final Rule e...
Gainers: Catabasis Pharmaceuticals (CATB) +44%, iBio (IBIO) +21%, Cellectar Biosciences (CLRB) +21%, Intec Pharma (NTEC) +18%, Sio Gene Therapies (SIOX) +18%.Losers: Ovid Therapeutics (OVID) -55%, Auris Medical (EARS) -35%, iRhythm Techno...
SAN FRANCISCO, Dec. 02, 2020 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, commented on the Centers for Medicare and Medicaid Services (CMS) Calendar Year 2021 Medicare Physicia...
News, Short Squeeze, Breakout and More Instantly...
iRhythm Technologies Inc. Company Name:
IRTC Stock Symbol:
NASDAQ Market:
iRhythm Technologies Inc. Website:
SAN FRANCISCO, July 18, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, prevent, and predict disease, today announced that it will release financial results for the second quarter 2024 ...
2024-06-20 06:30:05 ET Wolfe Research analyst issues OUTPERFORM recommendation for IRTC on June 20, 2024 05:01AM ET. IRTC was trading at $98.16 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst recommendations are : 1 - Strong B...
SAN FRANCISCO, June 17, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, announced today that the company has successfully launched the initial phases of it...